ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use-Reference-Cited by-同舟云学术

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Published:2010-12-14 Issue:24 Volume:122 Page:2619-2633
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

,Abraham Neena S.¹,Hlatky Mark A.²,Antman Elliott M.³,Bhatt Deepak L.²,Bjorkman David J.¹,Clark Craig B.²,Furberg Curt D.³,Johnson David A.¹,Kahi Charles J.¹,Laine Loren¹,Mahaffey Kenneth W.²,Quigley Eamonn M.¹,Scheiman James¹,Sperling Laurence S.³,Tomaselli Gordon F.³

Affiliation:

1. American College of Gastroenterology Representative.

2. American College of Cardiology Foundation Representative.

3. American Heart Association Representative.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIR.0b013e318202f701

Reference97 articles.

1. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

2. Public Health Advisory: Updated safety information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC). Available at: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm190825.htm. Accessed May 28 2010.

3. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

4. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

5. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

2. Proton-Pump Inhibitors and Risk of Bloodstream Infection without an Identifiable Source: a Hospital-Based Case-Control Study;Japanese Journal of Infectious Diseases;2024-07-31

3. A network meta-analysis: evaluating the efficacy and safety of concurrent proton pump inhibitors and clopidogrel therapy in post-PCI patients;Frontiers in Cardiovascular Medicine;2024-07-24

4. Prophylactic Proton Pump Inhibitors in Upper Gastrointestinal Bleeding: Impact and Underprescription in a French Multicentric Cohort;2024-07-19

5. Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study;Journal of Epidemiology and Global Health;2024-06-24